IART

IART

USD

Integra LifeSciences Holdings Corporation Common Stock

$11.300-0.090 (-0.790%)

Echtzeitkurs

Healthcare
Medizinprodukte
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$11.390

Hoch

$11.600

Tief

$11.220

Volumen

0.19M

Unternehmensfundamentaldaten

Marktkapitalisierung

880.2M

Branche

Medizinprodukte

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.22M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $11.05Aktuell $11.300Hoch $27.13

Ähnliche Nachrichten

Analyst Upgrades

Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13

Truist Securities analyst Ravi Misra reiterates Integra Lifesciences with a Hold and lowers the price target from $15 to $13.

Mehr anzeigen
Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13
Analyst Upgrades

Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences with a Sell and lowers the price target from $12 to $11.

Mehr anzeigen
Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11
Analyst Upgrades

JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13

JP Morgan analyst Robbie Marcus maintains Integra Lifesciences with a Underweight and raises the price target from $12 to $13.

Mehr anzeigen
JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13
GlobeNewswire

Integra LifeSciences Reports Third Quarter 2025 Financial Results

PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported financial results for the third quarter ending

Mehr anzeigen
Integra LifeSciences Reports Third Quarter 2025 Financial Results